Showing results (21-30 of 88) with videos related to
Sort By:
Pageof 9
Psychiatry (Edgmont (Pa. : Township))|October 27, 2009
Sleep disorders in substance abusers: how common are they?Youssef Mahfoud, Farid Talih, David Streem, et al.Neuropsychiatric Disease and Treatment|April 10, 2019
Predictors of achieving remission in schizophrenia patients treated with paliperidone palmitate 3-month formulationAbigail I Nash, Ibrahim Turkoz, Adam J Savitz, et al.Expert Opinion on Pharmacotherapy|November 17, 2017
Once-monthly injection of paliperidone palmitate in patients with recently diagnosed and chronic schizophrenia: a post-hoc comparison of efficacy and safetyTianmei Si, Jianmin Zhuo, Ibrahim Turkoz, et al.Advances in Therapy|November 5, 2017
Paliperidone Palmitate Improves and Maintains Functioning in Asia-Pacific Patients with SchizophreniaHongyan Zhang, Ibrahim Turkoz, Jianmin Zhuo, et al.Neuropsychiatric Disease and Treatment|March 19, 2020
Improvement of Negative Symptoms in Schizophrenia with Paliperidone Palmitate 1-Month and 3-Month Long-Acting Injectables: Results from a Phase 3 Non-Inferiority StudySrihari Gopal, Jagadish Gogate, Katalin Pungor, et al.International Clinical Psychopharmacology|August 15, 2017
Paliperidone palmitate 3-month treatment results in symptomatic remission in patients with schizophrenia: a randomized, multicenter, double-blind, and noninferiority studyAdam J Savitz, Haiyan Xu, Srihari Gopal, et al.Psychosomatics|December 31, 2005
Review of the literature on major mental disorders in adult patients with mitochondrial diseasesOmar Fattal, Kumar Budur, Aaron J Vaughan, et al.Expert Opinion on Pharmacotherapy|August 9, 2019
A post hoc analysis on hospitalization risk in Asian patients with schizophrenia switching to once-monthly paliperidone palmitate from oral antipsychoticsNan Li, Jian Min Zhuo, Ibrahim Turkoz, et al.Journal of Clinical Psychopharmacology|November 6, 2019
Pharmacokinetic-Pharmacodynamic Characterization of Relapse Risk for Paliperidone Palmitate 1-Month and 3-Month FormulationsAlberto Russu, Adam Savitz, Maju Mathews, et al.Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|April 18, 2019
Efficacy and safety of paliperidone palmitate 3-month formulation in Latin American patients with schizophrenia: A subgroup analysis of data from two large phase 3 randomized, double-blind studiesAdam J Savitz, Haiyan Xu, Srihari Gopal, et al.Pageof 9